Teladoc Health, Inc. (TDOC) EV/FCF Ratio: 6.55x
Is Teladoc Health, Inc.’s EV/FCF ratio high or low?
Teladoc Health, Inc.'s EV/FCF ratio of 6.55x is 61% below its 4-year average of 16.65x, near the low end of its 4-year range (5.07x–67.78x).
As of Tuesday, June 23, 2026. 10.08% below its 12-month average of 7.28x.
TDOC EV/FCF Ratio Chart
TDOC Average EV/FCF Ratio Chart
TDOC Current vs Average EV/FCF Ratio Chart
TDOC EV/FCF Ratio Metrics
EV/FCF RATIO
6.55x
EV/FCF RATIO AVG TTM
7.28x
EV/FCF RATIO AVG 3Y
7.53x
EV/FCF RATIO AVG 5Y
14.97x
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-10.08%
CURRENT VS 3Y AVG
-12.97%
CURRENT VS 5Y AVG
-56.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TDOC Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.37B | 6.55x | 7.28x | 7.53x | 14.97x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.03B | 40.10x | 41.43x | 32.72x | 28.43x |
| Shoulder Innovations, Inc. (SI)vs › | $366.44M | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.61B | 20.71x | 106.67x | 106.67x | 106.67x |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.48B | 112.99x | 83.93x | 71.73x | 71.73x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.60B | 23.65x | 25.16x | 42.80x | 51.06x |
| Oscar Health, Inc. (OSCR)vs › | $7.63B | 1.80x | 2.34x | 4.12x | 4.39x |
| Tempus AI, Inc. (TEM)vs › | $8.35B | N/A | N/A | N/A | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.75B | 30.03x | 21.59x | 28.91x | 35.16x |
Cash Flow Valuation Comparison
EV/FCF
6.5x
P/FCF
5.4x
FCF Yield
18.48%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
Teladoc Health, Inc. EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Teladoc Health, Inc. EV/FCF Ratio FAQ
- What is the EV/FCF ratio for Teladoc Health, Inc. (TDOC)?
- The EV/FCF ratio for TDOC stock is 6.55x.
- Is Teladoc Health, Inc.'s EV/FCF ratio high or low?
- Teladoc Health, Inc.'s EV/FCF ratio of 6.55x is 61% below its 4-year average of 16.65x, near the low end of its 4-year range (5.07x–67.78x).
- What is the TTM average EV/FCF ratio for Teladoc Health, Inc. (TDOC)?
- The TTM average EV/FCF ratio for TDOC stock is 7.28x.
- What is the 3Y average EV/FCF ratio for Teladoc Health, Inc. (TDOC)?
- The 3Y average EV/FCF ratio for TDOC stock is 7.53x.
- What is the 5Y average EV/FCF ratio for Teladoc Health, Inc. (TDOC)?
- The 5Y average EV/FCF ratio for TDOC stock is 14.97x.
Teladoc Health, Inc. EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-22 | 6.55x |
| 2026-06-18 | 6.90x |
| 2026-06-17 | 6.56x |
| 2026-06-16 | 6.54x |
| 2026-06-15 | 6.47x |
| 2026-06-12 | 6.38x |
| 2026-06-11 | 6.36x |
| 2026-06-10 | 6.16x |
| 2026-06-09 | 6.09x |
| 2026-06-08 | 6.20x |
| 2026-06-05 | 6.17x |
| 2026-06-04 | 6.36x |
| 2026-06-03 | 6.20x |
| 2026-06-02 | 6.52x |
| 2026-06-01 | 6.79x |
| 2026-05-29 | 6.57x |
| 2026-05-28 | 6.50x |
| 2026-05-27 | 5.85x |
| 2026-05-26 | 5.85x |
| 2026-05-22 | 5.83x |
| 2026-05-21 | 5.83x |
| 2026-05-20 | 5.77x |
| 2026-05-19 | 5.86x |
| 2026-05-18 | 5.67x |
| 2026-05-15 | 5.68x |
| 2026-05-14 | 5.86x |
| 2026-05-13 | 5.99x |
| 2026-05-12 | 5.97x |
| 2026-05-11 | 6.08x |
| 2026-05-08 | 6.32x |
| 2026-05-07 | 6.11x |
| 2026-05-06 | 6.00x |
| 2026-05-05 | 5.90x |
| 2026-05-04 | 5.87x |
| 2026-05-01 | 5.75x |
| 2026-04-30 | 5.47x |
| 2026-04-29 | 5.75x |
| 2026-04-28 | 5.78x |
| 2026-04-27 | 5.67x |
| 2026-04-24 | 5.59x |
| 2026-04-23 | 5.55x |
| 2026-04-22 | 5.72x |
| 2026-04-21 | 5.78x |
| 2026-04-20 | 5.86x |
| 2026-04-17 | 5.54x |
| 2026-04-16 | 5.65x |
| 2026-04-15 | 5.43x |
| 2026-04-14 | 5.20x |
| 2026-04-13 | 5.18x |
| 2026-04-10 | 5.09x |
| 2026-04-09 | 5.20x |
| 2026-04-08 | 5.22x |
| 2026-04-07 | 5.26x |
| 2026-04-06 | 5.26x |
| 2026-04-02 | 5.22x |
| 2026-04-01 | 5.23x |
| 2026-03-31 | 5.36x |
| 2026-03-30 | 5.12x |
| 2026-03-27 | 5.12x |
| 2026-03-26 | 5.41x |
| 2026-03-25 | 5.45x |
| 2026-03-24 | 5.34x |
| 2026-03-23 | 5.38x |
| 2026-03-20 | 5.28x |
| 2026-03-19 | 5.41x |
| 2026-03-18 | 5.34x |
| 2026-03-17 | 5.48x |
| 2026-03-16 | 5.31x |
| 2026-03-13 | 5.30x |
| 2026-03-12 | 5.29x |
| 2026-03-11 | 5.37x |
| 2026-03-10 | 5.45x |
| 2026-03-09 | 5.24x |
| 2026-03-06 | 5.07x |
| 2026-03-05 | 5.10x |
| 2026-03-04 | 5.11x |
| 2026-03-03 | 5.09x |
| 2026-03-02 | 5.13x |
| 2026-02-27 | 5.21x |
| 2026-02-26 | 5.28x |
| 2026-02-25 | 5.70x |
| 2026-02-24 | 5.60x |
| 2026-02-23 | 5.62x |
| 2026-02-20 | 5.78x |
| 2026-02-19 | 5.90x |
| 2026-02-18 | 5.71x |
| 2026-02-17 | 5.62x |
| 2026-02-13 | 5.70x |
| 2026-02-12 | 5.54x |
| 2026-02-11 | 5.73x |
| 2026-02-10 | 5.88x |
| 2026-02-09 | 5.99x |
| 2026-02-06 | 6.02x |
| 2026-02-05 | 5.77x |
| 2026-02-04 | 5.93x |
| 2026-02-03 | 6.11x |
| 2026-02-02 | 6.34x |
| 2026-01-30 | 6.41x |
| 2026-01-29 | 6.63x |
| 2026-01-28 | 6.66x |
| 2026-01-27 | 6.81x |
| 2026-01-26 | 7.15x |
| 2026-01-23 | 7.19x |
| 2026-01-22 | 7.20x |
| 2026-01-21 | 7.04x |
| 2026-01-20 | 6.96x |
| 2026-01-16 | 7.14x |
| 2026-01-15 | 7.36x |
| 2026-01-14 | 7.43x |
| 2026-01-13 | 7.77x |
| 2026-01-12 | 8.00x |
| 2026-01-09 | 8.19x |
| 2026-01-08 | 8.32x |
| 2026-01-07 | 8.28x |
| 2026-01-06 | 8.66x |
| 2026-01-05 | 8.03x |
| 2026-01-02 | 7.82x |
| 2025-12-31 | 7.78x |
| 2025-12-30 | 7.77x |
| 2025-12-29 | 7.72x |
| 2025-12-26 | 7.88x |
| 2025-12-24 | 8.00x |
| 2025-12-23 | 7.96x |
| 2025-12-22 | 8.01x |
| 2025-12-19 | 7.98x |
| 2025-12-18 | 7.90x |
| 2025-12-17 | 8.00x |
| 2025-12-16 | 8.14x |
| 2025-12-15 | 8.08x |
| 2025-12-12 | 8.26x |
| 2025-12-11 | 8.33x |
| 2025-12-10 | 8.39x |
| 2025-12-09 | 8.40x |
| 2025-12-08 | 8.27x |
| 2025-12-05 | 8.30x |
| 2025-12-04 | 8.47x |
| 2025-12-03 | 8.25x |
| 2025-12-02 | 8.22x |
| 2025-12-01 | 8.17x |
| 2025-11-28 | 8.30x |
| 2025-11-26 | 8.18x |
| 2025-11-25 | 8.19x |
| 2025-11-24 | 8.00x |
| 2025-11-21 | 7.74x |
| 2025-11-20 | 7.57x |
| 2025-11-19 | 7.82x |
| 2025-11-18 | 7.78x |
| 2025-11-17 | 7.56x |
| 2025-11-14 | 7.71x |
| 2025-11-13 | 7.84x |
| 2025-11-12 | 8.19x |
| 2025-11-11 | 8.27x |
| 2025-11-10 | 8.22x |
| 2025-11-07 | 8.25x |
| 2025-11-06 | 8.33x |
| 2025-11-05 | 8.72x |
| 2025-11-04 | 8.64x |
| 2025-11-03 | 8.79x |
| 2025-10-31 | 9.22x |
| 2025-10-30 | 9.32x |
| 2025-10-29 | 8.60x |
| 2025-10-28 | 8.70x |
| 2025-10-27 | 9.25x |
| 2025-10-24 | 9.63x |
| 2025-10-23 | 8.91x |
| 2025-10-22 | 8.69x |
| 2025-10-21 | 8.96x |
| 2025-10-20 | 9.22x |
| 2025-10-17 | 8.85x |
| 2025-10-16 | 9.26x |
| 2025-10-15 | 9.19x |
| 2025-10-14 | 9.18x |
| 2025-10-13 | 8.61x |
| 2025-10-10 | 8.40x |
| 2025-10-09 | 9.12x |
| 2025-10-08 | 9.32x |
| 2025-10-07 | 8.71x |
| 2025-10-06 | 8.88x |
| 2025-10-03 | 9.25x |
| 2025-10-02 | 8.81x |
| 2025-10-01 | 8.24x |
| 2025-09-30 | 8.18x |
| 2025-09-29 | 8.57x |
| 2025-09-26 | 8.54x |
| 2025-09-25 | 8.36x |
| 2025-09-24 | 8.74x |
| 2025-09-23 | 8.71x |
| 2025-09-22 | 8.56x |
| 2025-09-19 | 8.36x |
| 2025-09-18 | 8.62x |
| 2025-09-17 | 8.32x |
| 2025-09-16 | 8.29x |
| 2025-09-15 | 8.13x |
| 2025-09-12 | 8.13x |
| 2025-09-11 | 8.21x |
| 2025-09-10 | 7.98x |
| 2025-09-09 | 8.24x |
| 2025-09-08 | 8.27x |
| 2025-09-05 | 8.25x |
| 2025-09-04 | 8.09x |
| 2025-09-03 | 8.20x |
| 2025-09-02 | 8.10x |
| 2025-08-29 | 8.18x |
| 2025-08-28 | 8.31x |
| 2025-08-27 | 8.18x |
| 2025-08-26 | 8.24x |
| 2025-08-25 | 8.13x |
| 2025-08-22 | 8.13x |
| 2025-08-21 | 7.72x |
| 2025-08-20 | 7.75x |
| 2025-08-19 | 7.85x |
| 2025-08-18 | 7.98x |
| 2025-08-15 | 8.00x |
| 2025-08-14 | 7.82x |
| 2025-08-13 | 7.93x |
| 2025-08-12 | 7.46x |
| 2025-08-11 | 7.38x |
| 2025-08-08 | 7.53x |
| 2025-08-07 | 7.52x |
| 2025-08-06 | 7.56x |
| 2025-08-05 | 7.53x |
| 2025-08-04 | 7.54x |
| 2025-08-01 | 7.51x |
| 2025-07-31 | 7.74x |
| 2025-07-30 | 7.90x |
| 2025-07-29 | 8.26x |
| 2025-07-28 | 8.83x |
| 2025-07-25 | 8.83x |
| 2025-07-24 | 8.83x |
| 2025-07-23 | 9.15x |
| 2025-07-22 | 9.01x |
| 2025-07-21 | 8.94x |
| 2025-07-18 | 8.70x |
| 2025-07-17 | 8.69x |
| 2025-07-16 | 8.56x |
| 2025-07-15 | 8.58x |
| 2025-07-14 | 8.88x |
| 2025-07-11 | 8.93x |
| 2025-07-10 | 9.34x |
| 2025-07-09 | 9.37x |
| 2025-07-08 | 9.09x |
| 2025-07-07 | 8.72x |
| 2025-07-03 | 8.90x |
| 2025-07-02 | 8.95x |
| 2025-07-01 | 9.15x |
| 2025-06-30 | 9.26x |
| 2025-06-27 | 9.00x |
| 2025-06-26 | 8.70x |
| 2025-06-25 | 8.29x |
| 2025-06-24 | 8.66x |
| 2025-06-23 | 8.56x |
| 2025-06-20 | 7.73x |
| 2025-06-18 | 7.82x |
| 2025-06-17 | 7.88x |
| 2025-06-16 | 7.83x |
| 2025-06-13 | 7.69x |
| 2025-06-12 | 7.96x |
| 2025-06-11 | 8.17x |
| 2025-06-10 | 8.15x |
| 2025-06-09 | 8.15x |
Showing the most recent 260 of 1,480 data points. The chart above shows the full history.
Related Metrics
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita